Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: fatwollit

The debate on the current litigation appears to be allegations that Leckrone was working some sort of "buy-one-get two-free" program.

What if HTC were willing to purchase an MMP Portfolio license but Leckrone was trying to make it conditional on them also purchasing one or more of the other portfolio licences?

Might that be why the "tidal wave" has yet to arrive?

Just thinking aloud.

.

.

.

Be well

Share
New Message
Please login to post a reply